SCHEMBL21754731

SCHEMBL21754731

CC1OC(OO)C(O)C(O)C1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FUCA1 P04066 2/20 0.39
▸ CA9 Q16790 3/20 0.36
▸ CA12 O43570 2/20 0.36
▸ AMY1A P0DUB6 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ AKR1B1 P15121 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ FASN P49327 1/20 0.32
▸ PTGS1 P23219 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ GAA P10253 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ STAT3 P40763 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ NQO2 P16083 1/20 0.31
▸ IDO1 P14902 1/20 0.31
▸ SLCO2B1 O94956 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11883382 0.84 AMY1A (0.43) FUCA1CA9CA12AMY1ACA2
SCHEMBL25626385 0.84 AMY1A (0.43) FUCA1CA9CA12AMY1ACA2
SCHEMBL21303568 0.84 AMY1A (0.43) FUCA1CA9CA12AMY1ACA2
SCHEMBL29482063 0.84 AMY1A (0.43) FUCA1CA9CA12AMY1ACA2
SCHEMBL24605082 0.82 M6PR (0.44) FUCA1CA9CA12AMY1ACA2
SCHEMBL2502348 0.82 M6PR (0.44) FUCA1CA9CA12AMY1ACA2
SCHEMBL10268031 0.82 M6PR (0.44) FUCA1CA9CA12AMY1ACA2
SCHEMBL3384820 0.82 M6PR (0.44) FUCA1CA9CA12AMY1ACA2
SCHEMBL13510798 0.82 M6PR (0.44) FUCA1CA9CA12AMY1ACA2
SCHEMBL2743468 0.82 M6PR (0.44) FUCA1CA9CA12AMY1ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570164-B2 Steviol glycosides, their compositions and their purification THE COCA-COLA COMPANY (US) 2020-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570164-B2 Steviol glycosides, their compositions and their purification TAS2R7, TAS2R31, TAS2R40 FUCA1 298/4885CA9 899/4885CA12 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback